Mylan Inc. is a pharmaceutical company based in New York, New York, specializing in the development, manufacturing, and distribution of a wide range of medications. Situated in the heart of the city at 405 Lexington Avenue, the company serves as a significant player in the pharmaceutical sector, contributing to healthcare through the provision of generic and specialty pharmaceuticals. Mylan’s location within New York positions it strategically to collaborate with medical professionals, healthcare institutions, and other industry stakeholders.
The company focuses on delivering essential medicines that address various therapeutic areas, supporting patient care with a commitment to quality and safety. As a pharmaceutical company, Mylan works to ensure the availability of affordable medication options to meet the needs of diverse populations. Its operations include rigorous quality control and adherence to regulatory standards, reflecting the complex and highly regulated nature of the pharmaceutical industry.
Mylan Inc. also emphasizes research and development efforts aimed at enhancing existing drug formulations and exploring new treatment possibilities. By integrating scientific innovation with manufacturing expertise, the company contributes to advancements in pharmaceutical technology. This approach helps address evolving health challenges and supports public health initiatives.
Operating in a dynamic market environment, Mylan maintains communication channels such as a dedicated phone line to assist clients and partners. Its presence in New York allows access to a broad network of healthcare providers and industry professionals, fostering collaboration and continuous improvement in pharmaceutical services.


































